Mupirocin is an antibiotic used topically to treat bacterial skin infections, such as impetigo [1]. It works by inhibiting bacterial protein synthesis, specifically by binding to and reversibly inhibiting bacterial isoleucyl-tRNA synthetase [2]. This prevents the incorporation of isoleucine into proteins, thereby halting bacterial growth and replication [2].
How is Mupirocin available?
Mupirocin is available in several topical formulations, including ointments and creams. It is also available as a nasal ointment [1].
What bacterial infections does Mupirocin treat?
Mupirocin is effective against a range of Gram-positive bacteria, including Staphylococcus aureus and Streptococcus pyogenes, which are common causes of skin infections [1][3]. It is particularly useful for treating impetigo, a highly contagious skin infection [1]. It is also used to treat secondary bacterial infections of the skin and to help prevent skin infections in certain situations [1].
What are the side effects of Mupirocin?
Common side effects of topical mupirocin can include local skin reactions such as burning, stinging, itching, redness, or dryness at the application site [1]. Systemic side effects are rare due to limited absorption through the skin [1].
Does Mupirocin have patent protection?
Mupirocin itself is an older drug, and the original patents for its development have long expired [4]. However, specific formulations or novel delivery systems incorporating mupirocin may have independent patent protection [4]. DrugPatentWatch.com provides information on pharmaceutical patents, including those related to antibiotics like mupirocin [5].
Are there alternatives to Mupirocin?
Alternative topical antibiotics for skin infections include bacitracin and neomycin, although resistance patterns can vary [3]. For more severe or widespread infections, oral or intravenous antibiotics may be necessary [3]. The choice of antibiotic depends on the specific bacteria causing the infection and local resistance patterns [3].